According to our research report, in 2022, the Global Hormone Replacement Therapy for Menopause Indication Market was valued at USD 30.46 million and is projected to reach a market size of USD 45 million by 2030. Over the forecast period of 2023-2030, the market is projected to grow at a CAGR of 5%.
Industry Overview
When the body is unable to produce enough natural hormones, hormone replacement therapy (HRT) is used to address the condition. For instance, thyroid and human growth hormone patients may receive hormone replacement treatment. Additionally, HRT was frequently administered to menopausal women for the prevention of osteoporosis as well as the relief of symptoms such as hot flashes, night sweats, sleep disturbances, psychological issues, and genito-urinary issues (urinary frequency and vaginal dryness). In addition, the poll of 2,000 American women between the ages of 30 and 60 revealed that roughly 47% of the population has dealt with the signs of a hormone imbalance in 2019.
The prevalence of menopausal disorders is on the rise, and women are becoming more aware of the problems associated with post-menopause, which are two key contributors to the expansion of the global market for hormone replacement therapy. New launches of hormone replacement therapy are also anticipated to make a significant contribution to the expansion of the hormone replacement therapy market. However, throughout the projected period, it is anticipated that the negative effects of hormone replacement therapy and the high cost of treatment will restrain market expansion. The development of bioidentical hormone replacement treatment and the use of telemedicine for hormone replacement therapy, on the other hand, are anticipated to create lucrative opportunities for the expansion of the worldwide hormone replacement therapy market shortly.
5,451 COVID cases associated with HRT (estrogen therapy treatment) experienced a 78 % decrease in infection and mortality rate, according to a study conducted by the Oxford-Royal College of General Practitioners Research and Surveillance Centre on 1.8 million medical records of women from 465 general practitioners. Males typically have more serious infections, greater hospitalization and fatality rates, and more severe infections overall.
Impact of Covid-19 on the industry
In late December, the coronavirus (COVID-19) was found in the Chinese city of Wuhan's Hubei province. A virus called the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that spreads from person to person is the cause of the illness. The market for hormone replacement therapy has been adversely affected by the adoption of lockdown. The new coronavirus also exhibits a broad range of clinical manifestations, severity, and mortality rates. Additionally, reproductive treatment after menopause has been impacted by the pandemic because of data indicating that declining estrogen levels could put older women at risk for the illness and that hormone withdrawal could hasten the progression of COVID-19.
The administration of estradiol through a transdermal patch for a brief period—7 days—will be used in phase 2 clinical research started by Stony Brook University in April 2020 to examine the function of estrogen in lowering the severity of COVID-19 symptoms in comparison to standard therapy. As a result of the aforementioned causes, hormone replacement therapy is anticipated to play a promising role in the development of innovative medicines for the efficient treatment of SARS-CoV2 virus infection, which may cause the studied market to expand during the pandemic.
Market Drivers
Increasing awareness about hormone deficiency will drive the market growth
Growing public awareness of hormone deficiencies and diseases is anticipated to fuel market expansion. For instance, the UK-based non-governmental organization Child Growth Foundation supports individuals with uncommon growth hormone problems. To enhance patients' quality of life, this group offers information and support to patients, carers, and medical professionals.
Increasing research and development in the industry will drive the market growth
New goods are being introduced to the market as a result of key firms' growing involvement in the development of novel medicines. For instance, Ascendis Pharma A/S gained market clearance from the European Commission in January 2022 for their medicine SKYTROFA, which is used to treat growth hormone abnormalities in children and adolescents. This medicine is the first once-weekly therapy for pediatric growth hormone insufficiency.
Combination Hormone Replacement Therapy Associated with Cancer
Hormone replacement treatment use can promote the growth of malignant cells.
Even if administered for a brief period, combined hormone replacement therapy (combination of progesterone and estrogen) can raise the risk of breast cancer by 75%. The U.S. Women's Health Initiative claims that using combination hormone replacement treatment increases the risk of developing ovarian and uterine cancer, among other cancers. This factor is anticipated to limit the expansion in the use of hormone replacement treatment in the ensuing years. Blood clots, cardiac issues, and other conditions linked to hormone replacement treatment are also anticipated to hurt the market's expansion.
Market Restraints
The high cost associated with the therapy will challenge the market growth
The expensive expense of hormonal replacement therapy treatment, however, may limit market expansion. For instance, the annual cost of hormone replacement treatment injections ranges from USD 288 to USD 1,440 for patients with insurance and from USD 480 to USD 4,800 for those without insurance.
HORMONE REPLACEMENT THERAPY FOR MENOPAUSE INDICATION MARKET REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2022 - 2030 |
|
Base Year |
2022 |
|
Forecast Period |
2023 - 2030 |
|
CAGR |
5% |
|
Segments Covered |
By Product Type, Route of Administration, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Key Companies Profiled |
Eli Lilly and Company, Bayer AG, Noven Pharmaceuticals, Inc., Pfizer Inc., Merck & Co., Inc., Viatris, Inc., Novo Nordisk A/S, F. Hoffmann-La Roche Ltd., ASCEND Therapeutics US, LLC., AbbVie, Inc. |
This research report on the global hormone replacement therapy for menopause market has been segmented and sub-segmented based on, and Geography & region.
The HRT market is divided based on product into testosterone replacement therapy, thyroid replacement therapy, parathyroid hormone replacement therapy, and estrogen and progesterone replacement therapy. In 2021, the sector for estrogen and progesterone replacement therapy had the biggest market share, with 53.15 %. An increase in the number of women experiencing menopause was blamed for the dominance. The American Congress of Obstetricians and Gynecologists estimates that 6,000 women in the United States go through menopause every day. Due to rising incidence and more product penetration, the parathyroid hormone replacement market is anticipated to develop at the quickest rate throughout the forecast period. The National Organization for Rare Disease's 2021 database estimates that 70,000 Americans have hypoparathyroidism. In the section on parathyroid hormone, only one product has been approved, i.e., Natpara.
The HRT market is divided into oral, parenteral, transdermal, and other segments based on the route of administration. Because it is so easily administered and has a high prescription rate, the oral segment dominated the market in 2021. Tablets and pills are typically included in HRT medicines. During the projected time, the parenteral segment is anticipated to have profitable expansion. The category is estimated to grow as a result of improvements in parenteral drug delivery techniques, such as pen-based medication delivery, which are estimated to increase patient compliance and simplify administration. The Humatrope HumatroPen, Norditropin FlexPro Pen, and Genotropin Mixer Pen are a few of the well-known items offered in pen form.
In addition, the introduction of a new long-acting growth hormone injectable is anticipated to stimulate segment expansion. For instance, the Ministry of Health, Labour and Welfare of Japan granted permission for the commercialization of NGENLA to treat growth hormone problems in January 2022 to Pfizer, Inc. and OPKO Health, Inc. With a once-weekly treatment frequency, this product is the next-generation long-acting growth hormone injection.
With a share of 37.54 % in the global market for hormone replacement treatment in 2021, North America led the way and is projected to continue dominating during the forecast period. The biggest market share in the area is a result of several reasons, including significant product launches, manufacturer collaboration agreements, and benevolent reimbursement policies. For instance, Novo Nordisk A/Sogroya S's (somapacitan-beco), a medication for HGH replacement therapy, received FDA approval in August 2020. When an adult is diagnosed with a growth hormone shortage, this medication is given subcutaneously once a week.
According to estimates, the region with the quickest growth will be the Asia-Pacific. In women in East Asian nations, the prevalence of vasomotor symptoms related to menopause has been found to range from 43% to 83 %, according to the Journal of the North American Menopause Society (May 2022). Thus, it is anticipated that the region's demand for hormone replacement therapy will increase as more women enter menopause.
Global Hormone Replacement Therapy for Menopause Indication- By Companies
NOTABLE HAPPENINGS IN THE GLOBAL HORMONE REPLACEMENT THERAPY FOR MENOPAUSE INDICATION MARKET IN THE RECENT PAST:
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Specify your preferred Countries, Segments, or timeframes
Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.
